Posted on May 8, 2018 by Sitemaster
The following infographic was also issued today by the U.S. Preventive Services Task Force (USPSTF) and offers guidance as to the appropriateness of prostate cancer screening for an average, 55- to 69-year-old American male with no specific, known risk factors for prostate cancer: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: cancer, infographic, prostate, risk, screening | 8 Comments »
Posted on December 14, 2017 by Sitemaster
Earlier this year the American Society for Clinical Oncology (ASCO) worked with the Harris Poll to put in place ASCO’s first annual National Cancer Opinion Survey. We thought many of our readers might be interested in the findings. … READ MORE …
Filed under: Uncategorized | Tagged: American, cancer, perception, public | Leave a comment »
Posted on January 6, 2017 by Sitemaster
A new article in the journal Urologic Oncology has highlighted an association between the occurrence of advanced bladder cancer and the related finding of prostate cancer among such patients who have their prostate removed along with their bladder at the time of initial surgery for the bladder cancer (i.e., a radical cystoprostatectomy). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: advanced, bladder, cancer, cystectomy, cystoprostatectomy, risk | 7 Comments »
Posted on June 14, 2016 by Sitemaster
A newly published article in the Journal of Clinical Oncology has suggested that PSA testing between 40 and 59 years of age may be able to predict for risk of clinically significant prostate cancer later in life. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: cancer, Diagnosis, lethal, prostate, risk | 11 Comments »
Posted on May 11, 2016 by Sitemaster
According to a media report on the MarketWatch web site, a company called OncBioMune is to initiate Phase II clinical trials of a new type of prostate cancer vaccine (ProscaVax). … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: cancer, localized, Phase II, prostate, trial, vaccine | 2 Comments »
Posted on March 5, 2016 by Sitemaster
Some of the media (see this Medscape article) have already pounced on a meta-analysis on this topic published by a group of researchers from the University of Toronto. The media misguidedly focus on relative risk rather than absolute risk. We examined this very complex subject last year (see this link). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: absolute, cancer, radiation, real, relative, risk, second, therapy | Leave a comment »
Posted on February 9, 2016 by Sitemaster
It has been a couple of weeks now since Vice President Biden started work on the cancer “moon shot” initiative that President Obama announced during the State of the Union speech to Congress on January 12. … READ MORE …
Filed under: Uncategorized | Tagged: cancer, data, efficiency, moon shot | 3 Comments »
Posted on November 17, 2015 by Sitemaster
We may be seeing the beginning of a real turning point in opinions about the role of testosterone replacement therapy (TRT) in men who have been treated for prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cancer, hypogonadal, replacement, testosterone, TRT | 3 Comments »
Posted on November 9, 2015 by Sitemaster
In an article in the October 25 issue of The ASCO Post, Dr. Jonas de Souza of the University of Chicago has introduced a new initiative to help all cancer patients and their doctors address the increasing problems associated with the costs of cancer care. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: action, cancer, care, cost, financial, research, toxicity | Leave a comment »
Posted on October 29, 2015 by Sitemaster
Another article in this week’s issue of the New England Medical Journal is going to re-fuel the fire among those who advocate for widespread, frequent screening of men for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: cancer, Diagnosis, incidence, metastasis, prostate, PSA, screening | 8 Comments »
Posted on October 13, 2015 by Sitemaster
According to an hypothesis just published by a group of researchers at the Dana-Farber Cancer Institute in Boston, they have identified “a new epigenetic program occurring as you transition from normal to tumor cells” in the development of prostate cancer. … READ MORE …
Filed under: Risk | Tagged: cancer, development, epigenetics, gene, programming, prostate | Leave a comment »
Posted on September 3, 2015 by Sitemaster
… for making the song and music video “Superman” available on Youtube and the song downloadable via iTunes.
Getting men to actually face up to and talk about prostate cancer is one of the hardest challenges we face as a community. This type of publicity and activity is what will be needed to really get men to open up about what prostate cancer entails and what one has to do to deal with it.
Filed under: Living with Prostate Cancer | Tagged: cancer, Jimmy Charles, Superman, ZERO | Leave a comment »
Posted on September 1, 2015 by Sitemaster
The following statement was issued this morning by a new, patient-centric group of prostate cancer education, advocacy, and support organizations here in the USA. As indicated below, Prostate Cancer International — the parent organization behind The “New” Prostate Cancer InfoLink — is a founder member of the new group. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk | Tagged: advocacy, cancer, collaboration, patient-centricity, prostate | 24 Comments »
Posted on August 20, 2015 by Sitemaster
For years, physicians and their patients diagnosed with low-risk prostate cancer believed that those patients were at high risk for progressive disease over time. And physicians and their patients diagnosed with a form of breast cancer known as ductal carcinoma in situ or DCIS had similar beliefs. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: breast, cancer, DCIS, Diagnosis, over-treatment, quality of life, risk | 2 Comments »
Posted on July 14, 2015 by Sitemaster
This type of heading in media stories and press releases tends to drive your Sitemaster to distraction because there is almost invariably a major “may” or a “possibly” in the actual story when you get into the details. However, in this particular case there may be some justification for the headline. … READ MORE …
Filed under: Drugs in development | Tagged: cancer, CC-115, DNA-PKcs, inhibitor, repair | 2 Comments »